MicroRNA Expression Profile Analysis Reveals Diagnostic Biomarker for Human Prostate Cancer |
Liu, Dong-Fu
(Department of Urology, Yantai Yuhuangding Hospital)
Wu, Ji-Tao (Department of Urology, Yantai Yuhuangding Hospital) Wang, Jian-Ming (Department of Urology, Yantai Yuhuangding Hospital) Liu, Qing-Zuo (Department of Urology, Yantai Yuhuangding Hospital) Gao, Zhen-Li (Department of Urology, Yantai Yuhuangding Hospital) Liu, Yun-Xiang (Department of Urology, Yantai Yuhuangding Hospital) |
1 | Garcia DM, Baek D, Shin C, et al (2011). Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol, 18, 1139-46. DOI ScienceOn |
2 | Gautier L, Cope L, Bolstad BM, Irizarry RA (2004). affy--analysis of Affymetrix GeneChip data at the probe level. Bioinformatics, 20, 307-15. DOI |
3 | Hao P, Chen X, Geng H, et al (2004). Expression and implication of hypoxia inducible factor-1alpha in prostate neoplasm. J Huazhong Univ Sci Technolog Med Sci, 24, 593-5. DOI |
4 | Horvath S, Zhang B, Carlson M, et al (2006). Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA, 103, 17402-7. DOI |
5 | Iorio MV, Ferracin M, Liu CG, et al (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 65, 7065-70. DOI ScienceOn |
6 | Irizarry RA, Hobbs B, Collin F, et al (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-64. DOI ScienceOn |
7 | John B, Enright AJ, Aravin A, et al (2004). Human MicroRNA targets. PLoS Biol, 2, e363. DOI ScienceOn |
8 | Kanehisa M (2002). The KEGG database. Novartis Found Symp, 247, 91-101; discussion -3, 19-28, 244-52. DOI |
9 | Kimbro KS, Simons JW (2006). Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer, 13, 739-49. DOI ScienceOn |
10 | Kozomara A, Griffiths-Jones S (2011). miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res, 39, D152-7. DOI |
11 | Krek A, Grun D, Poy MN, et al (2005). Combinatorial microRNA target predictions. Nat Genet, 37, 495-500. DOI ScienceOn |
12 | Lee EJ, Gusev Y, Jiang J, et al (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer, 120, 1046-54. |
13 | Lee RC, Feinbaum RL, Ambros V (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 75, 843-54. DOI ScienceOn |
14 | Linton DK, Hamdy FC (2004). Early diagnosis and surgical management of prostate cancer. Ann Urol (Paris), 38, 137-47. DOI |
15 | Logothetis CJ, Lin SH (2005). Osteoblasts in prostate cancer metastasis to bone. Nat Rev Cancer, 5, 21-8. DOI |
16 | Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. DOI ScienceOn |
17 | Mattie MD, Benz CC, Bowers J, et al (2006). Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer, 5, 24. DOI ScienceOn |
18 | McCarron SL, Edwards S, Evans PR, et al (2002). Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res, 62, 3369-72. |
19 | Min H, Yoon S (2010). Got target? Computational methods for microRNA target prediction and their extension. Exp Mol Med, 42, 233-44. 과학기술학회마을 DOI |
20 | Murakami Y, Yasuda T, Saigo K, et al (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 25, 2537-45. DOI ScienceOn |
21 | O'Donnell KA, Wentzel EA, Zeller KI, et al (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature, 435, 839-43. DOI ScienceOn |
22 | Ozen M, Creighton CJ, Ozdemir M, Ittmann M (2008). Widespread deregulation of microRNA expression in human prostate cancer. Oncogene, 27, 1788-93. DOI |
23 | Porkka KP, Pfeiffer MJ, Waltering KK, et al (2007). MicroRNA expression profiling in prostate cancer. Cancer Res, 67, 6130-5. DOI ScienceOn |
24 | Schaefer A, Jung M, Miller K, et al (2010). Suitable reference genes for relative quantification of miRNA expression in prostate cancer. Exp Mol Med, 42, 749-58. DOI |
25 | Schaefer A, Jung M, Mollenkopf HJ, et al (2010). Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer, 126, 1166-76. |
26 | Semenza GL (2003). Targeting HIF-1 for cancer therapy. Nat Rev Cancer, 3, 721-32. DOI |
27 | Sempere LF, Christensen M, Silahtaroglu A, et al (2007). Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res, 67, 11612-20. DOI |
28 | Sfar S, Hassen E, Saad H, et al (2006). Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome. Cytokine, 35, 21-8. DOI |
29 | Shen MM, Abate-Shen C (2010). Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev, 24, 1967-2000. DOI |
30 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
31 | Szklarczyk D, Franceschini A, Kuhn M, et al (2011). The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res, 39, D561-8. DOI |
32 | Team RDC (2011). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. |
33 | Tong AW, Fulgham P, Jay C, et al (2009). MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther, 16, 206-16. |
34 | van der Laan MJ, Dudoit S, Pollard KS (2004). Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives. Stat Appl Genet Mol Biol, 3, Article15. |
35 | Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA, 103, 2257-61. DOI ScienceOn |
36 | Wach S, Nolte E, Szczyrba J, et al (2012). MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int J Cancer, 130, 611-21. DOI |
37 | Wang Y, Shao C, Shi CH, et al (2005). Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism. Asian J Androl, 7, 375-80. DOI |
38 | Wightman B, Ha I, Ruvkun G (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 75, 855-62. DOI ScienceOn |
39 | Zhang JF, Fu WM, He ML, et al (2011). MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol, 8. |
40 | Zhong H, Agani F, Baccala AA, et al (1998). Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer. Cancer Res, 58, 5280-4. |
41 | Ambs S, Prueitt RL, Yi M, et al (2008). Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res, 68, 6162-70. DOI |
42 | Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-97. DOI ScienceOn |
43 | Benjamini YH, Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the royal statistical society Series B (Methodological), 57, 289-300. |
44 | Berezikov E, Guryev V, van de Belt J, et al (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120, 21-4. DOI ScienceOn |
45 | Bubendorf L, Schopfer A, Wagner U, et al (2000). Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol, 31, 578-83. DOI |
46 | Chan JM, Jou RM, Carroll PR (2004). The relative impact and future burden of prostate cancer in the United States. J Urol, 172, S13-6; discussion S7. DOI |
47 | Cummins JM, He Y, Leary RJ, et al (2006). The colorectal microRNAome. Proc Natl Acad Sci U S A, 103, 3687-92. DOI |
48 | Ferrara N, Gerber HP, LeCouter J (2003). The biology of VEGF and its receptors. Nat Med, 9, 669-76. DOI ScienceOn |